 | • レポートコード：QYR9ST03569 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、急性感音難聴治療の世界市場について調査・分析し、急性感音難聴治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（全身性ステロイド、抗ウイルス薬、血管拡張薬、カルボゲン療法、その他）、用途別（病院、耳科クリニック、外来診療所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の急性感音難聴治療市場動向 ・主要企業別マーケットシェア ・急性感音難聴治療の種類別市場規模2014-2019 （全身性ステロイド、抗ウイルス薬、血管拡張薬、カルボゲン療法、その他） ・急性感音難聴治療の用途別市場規模2014-2019 （病院、耳科クリニック、外来診療所） ・急性感音難聴治療の北米市場：主要企業・種類別/用途別市場規模 ・急性感音難聴治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・急性感音難聴治療の中国市場：主要企業・種類別/用途別市場規模 ・急性感音難聴治療の日本国内市場：主要企業・種類別/用途別市場規模 ・急性感音難聴治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・急性感音難聴治療のインド市場：主要企業・種類別/用途別市場規模 ・急性感音難聴治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Bristol-Myers Squibb Company、Allergan、Renate pharmaceutical、Merck、F. Hoffmann-La Roche、Eli Lilly and Company、Novartis、GlaxoSmithKline、Teva pharmaceuticals） ・急性感音難聴治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Acute Sensorineural hearing loss is also known as sudden hearing loss involves an acute unexplained sensorineural hearing loss. Acute Sensorineural hearing loss hearing loss is defined as more than 30 dB hearing decline, over at least three contiguous frequencies, occurring over a period of 72 hours or less. Mostly occur in one ear and its affects the inner ear. Ear infection, high noise, disruption in eardrum, viral infection, and various other causes are responsible for acute sensorineural hearing loss. Many diagnosis tools are available to identify or detect the acute sensorineural hearing loss. According to ASLHA, in America yearly estimated incidence of acute sensorineural hearing loss is 5 to 20 cases per 100,000 individual.Due to rapidly growing incidence of acute sensorineural hearing loss, rising aging population, increasing noise pollution are the driver for the acute sensorineural hearing loss treatment market and other driving forces are innovation and advancement in acute sensorineural hearing loss treatment therapeutic. However, the lack of diagnostic tools and less awareness of acute sensorineural hearing hamper Acute Sensorineural Hearing Loss treatment Market.
In 2018, the global Acute Sensorineural Hearing Loss Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Acute Sensorineural Hearing Loss Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Sensorineural Hearing Loss Treatment development in United States, Europe and China.
The key players covered in this study
Pfizer
Bristol-Myers Squibb Company
Allergan
Renate pharmaceutical
Merck
F. Hoffmann-La Roche
Eli Lilly and Company
Novartis
GlaxoSmithKline
Teva pharmaceuticals
Market segment by Type, the product can be split into
Systemic Steroids
Antiviral Medication
Vasodilators
Carbogen Therapy
Others
Market segment by Application, split into
Hospitals
Otology Clinics
Ambulatory Clinics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Acute Sensorineural Hearing Loss Treatment status, future forecast, growth opportunity, key market and key players.
To present the Acute Sensorineural Hearing Loss Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Acute Sensorineural Hearing Loss Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Sensorineural Hearing Loss Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Systemic Steroids
1.4.3 Antiviral Medication
1.4.4 Vasodilators
1.4.5 Carbogen Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Acute Sensorineural Hearing Loss Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Otology Clinics
1.5.4 Ambulatory Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Acute Sensorineural Hearing Loss Treatment Market Size
2.2 Acute Sensorineural Hearing Loss Treatment Growth Trends by Regions
2.2.1 Acute Sensorineural Hearing Loss Treatment Market Size by Regions (2014-2025)
2.2.2 Acute Sensorineural Hearing Loss Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Acute Sensorineural Hearing Loss Treatment Market Size by Manufacturers
3.1.1 Global Acute Sensorineural Hearing Loss Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Acute Sensorineural Hearing Loss Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Acute Sensorineural Hearing Loss Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Acute Sensorineural Hearing Loss Treatment Key Players Head office and Area Served
3.3 Key Players Acute Sensorineural Hearing Loss Treatment Product/Solution/Service
3.4 Date of Enter into Acute Sensorineural Hearing Loss Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-2019)
4.2 Global Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Acute Sensorineural Hearing Loss Treatment Market Size (2014-2019)
5.2 Acute Sensorineural Hearing Loss Treatment Key Players in United States
5.3 United States Acute Sensorineural Hearing Loss Treatment Market Size by Type
5.4 United States Acute Sensorineural Hearing Loss Treatment Market Size by Application
6 Europe
6.1 Europe Acute Sensorineural Hearing Loss Treatment Market Size (2014-2019)
6.2 Acute Sensorineural Hearing Loss Treatment Key Players in Europe
6.3 Europe Acute Sensorineural Hearing Loss Treatment Market Size by Type
6.4 Europe Acute Sensorineural Hearing Loss Treatment Market Size by Application
7 China
7.1 China Acute Sensorineural Hearing Loss Treatment Market Size (2014-2019)
7.2 Acute Sensorineural Hearing Loss Treatment Key Players in China
7.3 China Acute Sensorineural Hearing Loss Treatment Market Size by Type
7.4 China Acute Sensorineural Hearing Loss Treatment Market Size by Application
8 Japan
8.1 Japan Acute Sensorineural Hearing Loss Treatment Market Size (2014-2019)
8.2 Acute Sensorineural Hearing Loss Treatment Key Players in Japan
8.3 Japan Acute Sensorineural Hearing Loss Treatment Market Size by Type
8.4 Japan Acute Sensorineural Hearing Loss Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size (2014-2019)
9.2 Acute Sensorineural Hearing Loss Treatment Key Players in Southeast Asia
9.3 Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size by Type
9.4 Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size by Application
10 India
10.1 India Acute Sensorineural Hearing Loss Treatment Market Size (2014-2019)
10.2 Acute Sensorineural Hearing Loss Treatment Key Players in India
10.3 India Acute Sensorineural Hearing Loss Treatment Market Size by Type
10.4 India Acute Sensorineural Hearing Loss Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Acute Sensorineural Hearing Loss Treatment Market Size (2014-2019)
11.2 Acute Sensorineural Hearing Loss Treatment Key Players in Central & South America
11.3 Central & South America Acute Sensorineural Hearing Loss Treatment Market Size by Type
11.4 Central & South America Acute Sensorineural Hearing Loss Treatment Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.1.4 Pfizer Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.2.4 Bristol-Myers Squibb Company Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.2.5 Bristol-Myers Squibb Company Recent Development
12.3 Allergan
12.3.1 Allergan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.3.4 Allergan Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.3.5 Allergan Recent Development
12.4 Renate pharmaceutical
12.4.1 Renate pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.4.4 Renate pharmaceutical Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.4.5 Renate pharmaceutical Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.5.4 Merck Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.5.5 Merck Recent Development
12.6 F. Hoffmann-La Roche
12.6.1 F. Hoffmann-La Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.6.4 F. Hoffmann-La Roche Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.6.5 F. Hoffmann-La Roche Recent Development
12.7 Eli Lilly and Company
12.7.1 Eli Lilly and Company Company Details
12.7.2 Company Description and Business Overview
12.7.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.7.4 Eli Lilly and Company Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.7.5 Eli Lilly and Company Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.8.4 Novartis Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Details
12.9.2 Company Description and Business Overview
12.9.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.9.4 GlaxoSmithKline Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.9.5 GlaxoSmithKline Recent Development
12.10 Teva pharmaceuticals
12.10.1 Teva pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Acute Sensorineural Hearing Loss Treatment Introduction
12.10.4 Teva pharmaceuticals Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
12.10.5 Teva pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Acute Sensorineural Hearing Loss Treatment Key Market Segments
Table Key Players Acute Sensorineural Hearing Loss Treatment Covered
Table Global Acute Sensorineural Hearing Loss Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size Market Share by Type 2014-2025
Figure Systemic Steroids Figures
Table Key Players of Systemic Steroids
Figure Antiviral Medication Figures
Table Key Players of Antiviral Medication
Figure Vasodilators Figures
Table Key Players of Vasodilators
Figure Carbogen Therapy Figures
Table Key Players of Carbogen Therapy
Figure Others Figures
Table Key Players of Others
Table Global Acute Sensorineural Hearing Loss Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Otology Clinics Case Studies
Figure Ambulatory Clinics Case Studies
Figure Acute Sensorineural Hearing Loss Treatment Report Years Considered
Table Global Acute Sensorineural Hearing Loss Treatment Market Size 2014-2025 (Million US$)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Acute Sensorineural Hearing Loss Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Acute Sensorineural Hearing Loss Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Acute Sensorineural Hearing Loss Treatment Market Share by Regions 2014-2019
Figure Global Acute Sensorineural Hearing Loss Treatment Market Share by Regions 2014-2019
Figure Global Acute Sensorineural Hearing Loss Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Acute Sensorineural Hearing Loss Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Acute Sensorineural Hearing Loss Treatment Market Share by Manufacturers (2014-2019)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Share by Manufacturers in 2018
Table Global Acute Sensorineural Hearing Loss Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acute Sensorineural Hearing Loss Treatment Product/Solution/Service
Table Date of Enter into Acute Sensorineural Hearing Loss Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Acute Sensorineural Hearing Loss Treatment Market Size Share by Type (2014-2019)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size Market Share by Type (2014-2019)
Table Global Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Acute Sensorineural Hearing Loss Treatment Market Size Share by Application (2014-2019)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size Market Share by Application (2014-2019)
Figure Global Acute Sensorineural Hearing Loss Treatment Revenue Market Share by Application in 2018
Figure United States Acute Sensorineural Hearing Loss Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2018-2019)
Table United States Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Acute Sensorineural Hearing Loss Treatment Market Share by Type (2014-2019)
Table United States Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Acute Sensorineural Hearing Loss Treatment Market Share by Application (2014-2019)
Figure Europe Acute Sensorineural Hearing Loss Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2018-2019)
Table Europe Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Acute Sensorineural Hearing Loss Treatment Market Share by Type (2014-2019)
Table Europe Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Acute Sensorineural Hearing Loss Treatment Market Share by Application (2014-2019)
Figure China Acute Sensorineural Hearing Loss Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2018-2019)
Table China Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-20189) (Million US$)
Table China Acute Sensorineural Hearing Loss Treatment Market Share by Type (2014-2019)
Table China Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019) (Million US$)
Table China Acute Sensorineural Hearing Loss Treatment Market Share by Application (2014-2019)
Figure Japan Acute Sensorineural Hearing Loss Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2018-2019)
Table Japan Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Acute Sensorineural Hearing Loss Treatment Market Share by Type (2014-2019)
Table Japan Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Acute Sensorineural Hearing Loss Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2018-2019)
Table Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Share by Type (2014-2019)
Table Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Share by Application (2014-2019)
Figure India Acute Sensorineural Hearing Loss Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2018-2019)
Table India Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-2019) (Million US$)
Table India Acute Sensorineural Hearing Loss Treatment Market Share by Type (2014-2019)
Table India Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019) (Million US$)
Table India Acute Sensorineural Hearing Loss Treatment Market Share by Application (2014-2019)
Figure Central & South America Acute Sensorineural Hearing Loss Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2018-2019)
Table Central & South America Acute Sensorineural Hearing Loss Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Acute Sensorineural Hearing Loss Treatment Market Share by Type (2014-2019)
Table Central & South America Acute Sensorineural Hearing Loss Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Acute Sensorineural Hearing Loss Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Allergan Company Details
Table Allergan Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table Allergan Recent Development
Table Renate pharmaceutical Company Details
Table Renate pharmaceutical Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure Renate pharmaceutical Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table Renate pharmaceutical Recent Development
Table Merck Company Details
Table Merck Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table Merck Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Novartis Company Details
Table Novartis Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Teva pharmaceuticals Company Details
Table Teva pharmaceuticals Revenue in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)(Million US$)
Figure Teva pharmaceuticals Revenue Growth Rate in Acute Sensorineural Hearing Loss Treatment Business (2014-2019)
Table Teva pharmaceuticals Recent Development
Table Global Acute Sensorineural Hearing Loss Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size Share by Regions (2019-2025)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size Share by Regions in 2025
Figure United States Acute Sensorineural Hearing Loss Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Acute Sensorineural Hearing Loss Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Acute Sensorineural Hearing Loss Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Acute Sensorineural Hearing Loss Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Acute Sensorineural Hearing Loss Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Acute Sensorineural Hearing Loss Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Acute Sensorineural Hearing Loss Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size by Product (2019-2025)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size by Product in 2025
Table Global Acute Sensorineural Hearing Loss Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size by Application (2019-2025)
Figure Global Acute Sensorineural Hearing Loss Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
植込み型骨導補聴器の世界市場：インサイト・予測 A bone-anchored hearing aid (BAHA) is a surgically implanted device designed to treat hearing loss by transmitting the sounds it receives through direct bone conduction to the nerve fibers of the inner ear. The device consists of an externally worn receiver and sound processor, which resembles a sta…- 脱毛症（脱毛）治療の世界市場：市場規模・現状・予測 Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues.Changing lifestyle along with increase in stress level among working class population is expected to boost the demand for treatment of hair loss globally. Furthermore, rise in geriatrics popu…
- 急性腎障害治療の世界市場：市場規模・現状・予測 Acute kidney injury (AKI) is where your kidneys suddenly stop working properly. It can range from minor loss of kidney function to complete kidney failure.In 2018, the global Acute Kidney Injury Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, w…
- 急性腎障害治療及び管理の世界市場：市場規模・現状・予測 KI happens in people who are already sick and in the hospital. People who are in the intensive care unit (ICU) are even more likely than people who are in other units of the hospital to have AKI. This is because people who need to be in the ICU are already very sick.In 2018, the global Acute Kidney …
- 急性虚血性脳卒中診断及び治療の世界市場：市場規模・現状・予測 According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases.Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. Heart attacks and …